Sunday, December 7, 2025
ADVT 
National

Groups question delay in B.C. care home report

Darpan News Desk The Canadian Press, 25 Jan, 2021 08:04 PM
  • Groups question delay in B.C. care home report

British Columbia plans to release a report on COVID-19 outbreaks in long-term care homes today, but stakeholders consulted and the Opposition Liberals are questioning why the document wasn't released earlier.

The Ministry of Health commissioned the report by Ernst & Young to learn lessons from the first wave of the pandemic, and more than 40 groups were consulted and it was completed in the fall.

Mike Klassen, vice-president of public affairs with the B.C. Care Providers Association, says his group is concerned both about the delay in the report being released as well as the possibility that recommendations in it could have been acted upon sooner.

Health Minister Adrian Dix said last week that his government has implemented all the recommendations in the report and its assessment of the province's actions was "overwhelmingly favourable."

Opposition Leader Shirley Bond has said that people who had friends or relatives die in long-term care from COVID-19 deserve answers.

More than half of B.C.'s deaths from COVID-19 have been in long-term care facilities.

Jen Lyle, the chief executive officer of SafeCare B.C., says seeing the report earlier would have been nice but at this point just being able to see it will be help inform future pandemic responses.

Lyle says her group had flagged several concerns, including the confusion around messaging and orders from the province compared to local health authorities.

She adds that she hopes the health ministry looks into addressing the issues of staff shortages and access for mental health support for workers.

The B.C. Care Providers Association released their own report examining the response to COVID-19 in seniors care in November, and Klassen says the organization is interested to see what recommendations the government-commissioned report may have that are different.

"We're still seeing outbreaks, we're still seeing fatalities," he says. "Are there things we haven't done yet that our group and perhaps the people that were spoken to in this report have recommended and haven't been acted upon yet?"

MORE National ARTICLES

Doctors, nurses, paramedics waiting to vaccinate

Doctors, nurses, paramedics waiting to vaccinate
The former clinical nurse specialist now assists nurses, occupational therapists, physiotherapists and social workers integrate virtual care into their practices at a clinic in New Westminster, B.C.

Doctors, nurses, paramedics waiting to vaccinate

Drugs and cash found in secret compartment: Surrey RCMP

Drugs and cash found in secret compartment: Surrey RCMP
A hidden compartment was located inside the vehicle and several items were found inside including approximately $10,000 cash, and approximately 1 ounce of suspected cocaine.

Drugs and cash found in secret compartment: Surrey RCMP

Vancouver Police looking for witnesses in an East Vancouver ttack

Vancouver Police looking for witnesses in an East Vancouver ttack
Police were called by a witness for two men who were engaged in a physical altercation just after 2 a.m. on January 5 in in front of 769 East Hastings Street. During the altercation, the victim was stabbed by the suspect.

Vancouver Police looking for witnesses in an East Vancouver ttack

Snowbirds rush to vaccinate in Florida

Snowbirds rush to vaccinate in Florida
More than 329,000 people in Florida have already received their first doses, compared to fewer than 206,000 doses administered across Canada as of Thursday.

Snowbirds rush to vaccinate in Florida

Canada pushes back on U.S. solar product tariffs

Canada pushes back on U.S. solar product tariffs
The tariffs were imposed in 2018 and the federal government says they have caused Canadian exports of solar products to the U.S. to fall by up to 82 per cent.

Canada pushes back on U.S. solar product tariffs

Health Canada delays drug-pricing reforms

Health Canada delays drug-pricing reforms
Drug manufacturers and patient advocates have balked at the plan, citing concerns that the regulations could stifle scientific innovation and reduce access to therapies for rare diseases.

Health Canada delays drug-pricing reforms